Successful Proof Principal Mouse Trial with Chronoscreen™ Validated Compound

Chronos Therapeutics completes successful proof of principle mouse trial with a…


RDC5 Reduces the Levels of Toxic Protein Aggregates

In pre-clinical models, Chronos Therapeutics' patented compound RDC5 and CHR1…